0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Central Lab Market Size, Share & Trends Analysis Report by Service (Genetic Services, Biomarker Services, Microbiology Services), End-use (Pharmaceutical Companies, Biotechnology Companies), and Region with Growth Forecasts, 2025-2030- Product Image
Central Lab Market Size, Share & Trends Analysis Report by Service (Genetic Services, Biomarker Services, Microbiology Services), End-use (Pharmaceutical Companies, Biotechnology Companies), and Region with Growth Forecasts, 2025-2030- Product Image
New

Central Lab Market Size, Share & Trends Analysis Report by Service (Genetic Services, Biomarker Services, Microbiology Services), End-use (Pharmaceutical Companies, Biotechnology Companies), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 110 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5649359
Description Jump to:
The Central Lab Market was valued at USD 3.46 billion in 2024, and is projected to reach USD 5.04 billion by 2030, rising at a CAGR of 6.56%. The outsourcing of central lab work is a significant factor driving the market growth.

Outsourcing central lab work is a rising trend in the clinical trial industry, which is expected to create lucrative business opportunities for central labs. The investigators and sponsors outsource ~80% of the central lab work and prefer the labs that provide end-to-end integrated services.

Investment in R&D has witnessed a surge in past years, which can be attributed to the enhanced focus on the pharmaceutical industry during the pandemic. As we enter the third year of the pandemic, investment in science has enhanced the pipeline and several clinical trials have been initiated. Over the pandemic, activity in interventional studies grew steadily. The pharmaceutical industry developed a new way of conducting trials for the management of ongoing clinical trials during the pandemic.

The pandemic has also created new growth opportunities, with an increasing focus on mRNA vaccine development and investigations for several COVID-19 treatment options. However, sample handling, supply chain, and logistics play a significant role in the sample sent to clinical labs. These samples are highly sensitive and require fast logistics with temperature control, thereby maintaining sample stability to get the most accurate results.

The rise of small- and medium-scale central laboratories is intensifying the competition globally. The presence of small- and medium-scale central labs is highly prominent in developing regions such as the Asia-Pacific. These laboratories are becoming critical in the management of clinical trials globally owing to the availability of central laboratory services at 20%-35% lower prices, when compared to Europe and the U.S. Furthermore, the lower cost of conducting clinical trials in the developing economies facilitates the selection of central laboratories present in these regions, which can be attributed to lower logistic costs and presence near the trial location.

Central Lab Market Report Highlights

  • The genetic services segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the increasing significance of genetic analysis in clinical studies.
  • Strategic acquisitions are one of the factors influencing the changing dynamics of the market. For instance, players are acquired by medium and large-scale enterprises for enhancing their global reach and entering new business segments.
  • By end-use, the pharmaceutical companies held the largest market share of 44.78% in 2024, attributable to an increasing number of interventional studies and investment into research.
  • North America dominated the global market in 2024 with a share of 40.82%, the increasing need for genetic testing in clinical trials related to personalized healthcare in disease areas, such as diabetes & cancers.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service Outlook
2.2.2. End Use Outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Rising R&D investment in clinical trial
3.4.2. Escalating demand for novel drugs
3.4.3. Outsourcing of central lab work
3.4.4. Reducing the cost of drug research
3.5. Market Restraint Analysis
3.5.1. Logistics and sample handling
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Central Labs Market: Service Estimates & Trend Analysis
4.1. Central Lab Market: Service Movement Analysis
4.2. Genetic Services
4.2.1. Genetic Services Central Lab Market, 2018-2030 (USD Million)
4.3. Biomarker Services
4.3.1. Biomarker Services Central Lab Market, 2018-2030 (USD Million)
4.4. Microbiology Services
4.4.1. Microbiology Services Central Lab Market, 2018-2030 (USD Million)
4.5. Anatomic Pathology/Histology
4.5.1. Anatomic Pathology/Histology Central Lab Market, 2018-2030 (USD Million)
4.6. Specimen Management and Storage
4.6.1. Specimen Management and Storage Central Lab Market, 2018-2030 (USD Million)
4.7. Special Chemistry Services
4.7.1. Special Chemistry Services Central Lab Market, 2018-2030 (USD Million)
4.8. Others
4.8.1. Others Central Lab Market, 2018-2030 (USD Million)
Chapter 5. Central Labs Market: End Use Estimates & Trend Analysis
5.1. Central Lab Market: End-Use Movement Analysis
5.2. Pharmaceutical Companies
5.2.1. Pharmaceutical Companies Market, 2018-2030 (USD Million)
5.3. Biotechnology Companies
5.3.1. Biotechnology Companies Market, 2018-2030 (USD Million)
5.4. Academic and Research Institutes
5.4.1. Academic and Research Institutes Market, 2018-2030 (USD Million)
Chapter 6. Central Lab Market: Regional Estimates & Trend Analysis
6.1. Central Lab Market Share By Region, 2023 & 2030
6.2. North America
6.2.1. North America Central lab market, 2018-2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Regulatory Framework
6.2.2.4. Reimbursement Scenario
6.2.2.5. U.S. Central lab market, 2018-2030 (USD MILLION)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Regulatory Framework
6.2.3.4. Reimbursement Scenario
6.2.3.5. Canada Central lab market, 2018-2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Key Country Dynamics
6.2.4.2. Competitive Scenario
6.2.4.3. Regulatory Framework
6.2.4.4. Reimbursement Scenario
6.2.4.5. Mexico Central lab market, 2018-2030 (USD Million)
6.3. Europe
6.3.1. Europe Central lab market, 2018-2030 (USD Million)
6.3.2. Germany
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. Reimbursement Scenario
6.3.2.5. Germany Central lab market, 2018-2030 (USD Million)
6.3.3. UK
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Reimbursement Scenario
6.3.3.5. UK Central lab market, 2018-2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Reimbursement Scenario
6.3.4.5. France Central lab market, 2018-2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Regulatory Framework
6.3.5.4. Reimbursement Scenario
6.3.5.5. Italy Central lab market, 2018-2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Regulatory Framework
6.3.6.4. Reimbursement Scenario
6.3.6.5. Spain Central lab market, 2018-2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Regulatory Framework
6.3.7.4. Reimbursement Scenario
6.3.7.5. Denmark Central lab market, 2018-2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Regulatory Framework
6.3.8.4. Reimbursement Scenario
6.3.8.5. Sweden Central lab market, 2018-2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Regulatory Framework
6.3.9.4. Reimbursement Scenario
6.3.9.5. Norway Central lab market, 2018-2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Central lab market, 2018-2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Scenario
6.4.2.5. Japan Central lab market, 2018-2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Scenario
6.4.3.5. China Central lab market, 2018-2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. Reimbursement Scenario
6.4.4.6. India Central lab market, 2018-2030 (USD Million)
6.4.5. South Korea
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Reimbursement Scenario
6.4.5.5. South Korea Central lab market, 2018-2030 (USD Million)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Reimbursement Scenario
6.4.6.5. Australia Central lab market, 2018-2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Reimbursement Scenario
6.4.7.5. Thailand Central lab market, 2018-2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Central lab market, 2018-2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Scenario
6.5.2.5. Brazil Central lab market, 2018-2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Scenario
6.5.3.5. Argentina Central lab market, 2018-2030 (USD Million)
6.6. MEA
6.6.1. MEA Central lab market, 2018-2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Scenario
6.6.2.5. South Africa Central lab market, 2018-2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Scenario
6.6.3.5. Saudi Arabia Central lab market, 2018-2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Scenario
6.6.4.5. UAE Central lab market, 2018-2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Scenario
6.6.5.5. Kuwait Central lab market, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant’s overview
7.2. Financial performance
7.3. Participant categorization
7.3.1. Market Leaders
7.3.2. Central Lab Market Share Analysis, 2023
7.3.3. Company Profiles
7.3.3.1. ACM Global Laboratories
7.3.3.1.1. Company Overview
7.3.3.1.2. Financial Performance
7.3.3.1.3. Product Benchmarking
7.3.3.1.4. Strategic Initiatives
7.3.3.2. LabConnect
7.3.3.2.1. Company Overview
7.3.3.2.2. Financial Performance
7.3.3.2.3. Product Benchmarking
7.3.3.2.4. Strategic Initiatives
7.3.3.3. Cerba Research
7.3.3.3.1. Company Overview
7.3.3.3.2. Financial Performance
7.3.3.3.3. Product Benchmarking
7.3.3.3.4. Strategic Initiatives
7.3.3.4. Eurofins Scientific
7.3.3.4.1. Company Overview
7.3.3.4.2. Financial Performance
7.3.3.4.3. Product Benchmarking
7.3.3.4.4. Strategic Initiatives
7.3.3.5. Versiti (Cenetron)
7.3.3.5.1. Company Overview
7.3.3.5.2. Financial Performance
7.3.3.5.3. Product Benchmarking
7.3.3.5.4. Strategic Initiatives
7.3.3.6. Medicover Integrated Clinical Services (MICS) (Synevo Central Labs)
7.3.3.6.1. Company Overview
7.3.3.6.2. Financial Performance
7.3.3.6.3. Product Benchmarking
7.3.3.6.4. Strategic Initiatives
7.3.3.7. A.P. Møller Holding A/S (Unilabs)
7.3.3.7.1. Company Overview
7.3.3.7.2. Financial Performance
7.3.3.7.3. Product Benchmarking
7.3.3.7.4. Strategic Initiatives
7.3.3.8. Ampersand Capital Partners (Pacific Biomarkers)
7.3.3.8.1. Company Overview
7.3.3.8.2. Financial Performance
7.3.3.8.3. Product Benchmarking
7.3.3.8.4. Strategic Initiatives
7.3.3.9. Lambda Therapeutic Research Ltd
7.3.3.9.1. Company Overview
7.3.3.9.2. Financial Performance
7.3.3.9.3. Product Benchmarking
7.3.3.9.4. Strategic Initiatives
7.3.3.10. CIRION BioPharma Research Inc.
7.3.3.10.1. Company Overview
7.3.3.10.2. Financial Performance
7.3.3.10.3. Product Benchmarking
7.3.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 Global Central Lab Market, by Service, 2018-2030 (USD Million)
Table 3 Global Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 4 Global Central Lab Market, by Region, 2018-2030 (USD Million)
Table 5 North America Central Lab Market, by Country, 2018-2030 (USD Million)
Table 6 North America Central Lab Market, by Service, 2018-2030 (USD Million)
Table 7 North America Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 8 U.S. Central Lab Market, by Service, 2018-2030 (USD Million)
Table 9 U.S. Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 10 Canada Central Lab Market, by Service, 2018-2030 (USD Million)
Table 11 Canada Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 12 Mexico Central Lab Market, by Service, 2018-2030 (USD Million)
Table 13 Mexico Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 14 Europe Central Lab Market, by Country, 2018-2030 (USD Million)
Table 15 Europe Central Lab Market, by Service, 2018-2030 (USD Million)
Table 16 Europe Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 17 Germany Central Lab Market, by Service, 2018-2030 (USD Million)
Table 18 Germany Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 19 UK Central Lab Market, by Service, 2018-2030 (USD Million)
Table 20 UK Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 21 France Central Lab Market, by Service, 2018-2030 (USD Million)
Table 22 France Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 23 Italy Central Lab Market, by Service, 2018-2030 (USD Million)
Table 24 Italy Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 25 Spain Central Lab Market, by Service, 2018-2030 (USD Million)
Table 26 Spain Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 27 Denmark Central Lab Market, by Service, 2018-2030 (USD Million)
Table 28 Denmark Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 29 Sweden Central Lab Market, by Service, 2018-2030 (USD Million)
Table 30 Sweden Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 31 Norway Central Lab Market, by Service, 2018-2030 (USD Million)
Table 32 Norway Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 33 Asia Pacific Central Lab Market, by Country, 2018-2030 (USD Million)
Table 34 Asia Pacific Central Lab Market, by Service, 2018-2030 (USD Million)
Table 35 Asia Pacific Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 36 China Central Lab Market, by Service, 2018-2030 (USD Million)
Table 37 China Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 38 Japan Central Lab Market, by Service, 2018-2030 (USD Million)
Table 39 Japan Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 40 India Central Lab Market, by Service, 2018-2030 (USD Million)
Table 41 India Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 42 South Korea Central Lab Market, by Service, 2018-2030 (USD Million)
Table 43 South Korea Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 44 Australia Central Lab Market, by Service, 2018-2030 (USD Million)
Table 45 Australia Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 46 Thailand Central Lab Market, by Service, 2018-2030 (USD Million)
Table 47 Thailand Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 48 Latin America Central Lab Market, by Country, 2018-2030 (USD Million)
Table 49 Latin America Central Lab Market, by Service, 2018-2030 (USD Million)
Table 50 Latin America Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 51 Brazil Central Lab Market, by Service, 2018-2030 (USD Million)
Table 52 Brazil Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 53 Argentina Central Lab Market, by Service, 2018-2030 (USD Million)
Table 54 Argentina Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 55 Middle East & Africa Central Lab Market, by Service, 2018-2030 (USD Million)
Table 56 Middle East & Africa Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 57 South Africa Central Lab Market, by Service, 2018-2030 (USD Million)
Table 58 South Africa Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 59 Saudi Arabia Central Lab Market, by Service, 2018-2030 (USD Million)
Table 60 Saudi Arabia Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 61 UAE Central Lab Market, by Service, 2018-2030 (USD Million)
Table 62 UAE Central Lab Market, by End Use, 2018-2030 (USD Million)
Table 63 Kuwait Central Lab Market, by Service, 2018-2030 (USD Million)
Table 64 Kuwait Central Lab Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Central Lab Market Segmentation
Figure 8 Market Snapshot, 2024
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Global Central Lab Market: Service Movement Analysis
Figure 15 Global Central Lab Market, by Genetic Services, 2018-2030 (USD Million)
Figure 16 Global Central Lab Market, by Biomarker Services, 2018-2030 (USD Million)
Figure 17 Global Central Lab Market, by Anatomic Pathology/Histology, 2018-2030 (USD Million)
Figure 18 Global Central Lab Market, by Specimen Management & Storage, 2018-2030 (USD Million)
Figure 19 Global Central Lab Market, by Special Chemistry Services, 2018-2030 (USD Million)
Figure 20 Global Central Lab Market, by Others, 2018-2030 (USD Million)
Figure 21 Global Central Lab Market: End Use Movement Analysis
Figure 22 Global Central Lab Market, by Pharmaceutical Companies 2018-2030 (USD Million)
Figure 23 Global Central Lab Market, by Biotechnology Companies 2018-2030 (USD Million)
Figure 24 Global Central Lab Market, by Academic & Research Institutes, 2018-2030 (USD Million)
Figure 25 Regional Marketplace: Key Takeaways
Figure 26 Regional Outlook, 2023 & 2030
Figure 27 Global Central Lab Market: Region Movement Analysis
Figure 28 North America Central Lab Market, 2018-2030 (USD Million)
Figure 29 U.S. Central Lab Market, 2018-2030 (USD Million)
Figure 30 Canada Central Lab Market, 2018-2030 (USD Million)
Figure 31 Mexico Central Lab Market, 2018-2030 (USD Million)
Figure 32 Europe Central Lab Market, 2018-2030 (USD Million)
Figure 33 Germany Central Lab Market, 2018-2030 (USD Million)
Figure 34 UK Central Lab Market, 2018-2030 (USD Million)
Figure 35 France Central Lab Market, 2018-2030 (USD Million)
Figure 36 Italy Central Lab Market, 2018-2030 (USD Million)
Figure 37 Spain Central Lab Market, 2018-2030 (USD Million)
Figure 38 Denmark Central Lab Market, 2018-2030 (USD Million)
Figure 39 Sweden Central Lab Market, 2018-2030 (USD Million)
Figure 40 Norway Central Lab Market, 2018-2030 (USD Million)
Figure 41 Asia Pacific Central Lab Market, 2018-2030 (USD Million)
Figure 42 Japan Central Lab Market, 2018-2030 (USD Million)
Figure 43 China Central Lab Market, 2018-2030 (USD Million)
Figure 44 India Central Lab Market, 2018-2030 (USD Million)
Figure 45 Australia Central Lab Market, 2018-2030 (USD Million)
Figure 46 South Korea Central Lab Market, 2018-2030 (USD Million)
Figure 47 Thailand Central Lab Market, 2018-2030 (USD Million)
Figure 48 Latin America Central Lab Market, 2018-2030 (USD Million)
Figure 49 Brazil Central Lab Market, 2018-2030 (USD Million)
Figure 50 Argentina Central Lab Market, 2018-2030 (USD Million)
Figure 51 Middle East and Africa Central Lab Market, 2018-2030 (USD Million)
Figure 52 South Africa Central Lab Market, 2018-2030 (USD Million)
Figure 53 Saudi Arabia Central Lab Market, 2018-2030 (USD Million)
Figure 54 UAE Central Lab Market, 2018-2030 (USD Million)
Figure 55 Kuwait Central Lab Market, 2018-2030 (USD Million)

Companies Mentioned

The major companies featured in this Central Lab market report include:
  • ACM Global Laboratories
  • Labconnect
  • Cerba Research
  • Eurofins Scientific
  • Medicover Integrated Clinical Services (MICS) (Synevo Central Labs
  • Versiti (Cenetron)
  • A.P. Møller Holding A/S (Unilabs)
  • Ampersand Capital Partners (Pacific Biomarkers)
  • Lambda Therapeutics Research Ltd
  • Cirion Biopharma Research Inc.

Table Information

Report AttributeDetails
No. of Pages110
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.46 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.04 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Central Lab Market by Service Type, Therapeutic Area, Phase, End-User Industries - Global Forecast to 2030 - Product Image

Central Lab Market by Service Type, Therapeutic Area, Phase, End-User Industries - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End User (Pharma & CROs) & Region - Global Forecast to 2030 - Product Image

Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End User (Pharma & CROs) & Region - Global Forecast to 2030

  • Report
  • 311 Pages
  • Global
From
EUR$4,950USDGBP
Central Labs - Global Strategic Business Report - Product Image

Central Labs - Global Strategic Business Report

  • Report
  • 290 Pages
  • Global
From
EUR$5,850USDGBP
Central Lab Market Report 2025 - Product Image

Central Lab Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Clinical Trial Central Lab Service Sales Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Clinical Trial Central Lab Service Sales Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
EUR$4,850USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more